Clinical Trials Arena

Innovent’s GLP-1RA bests semaglutide’s glycaemic control in Phase III

Analysts at GlobalData forecast that GCG/GLP-1RA mazdutide will become a blockbuster seller in China for Innovent by 2030.
Clinical Trials Arena

Moderna scraps mRNA vaccine in congenital CMV on Phase III failure

While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...
clinicaltrialsarena

BridgeBio’s stock up as muscular dystrophy therapy meets Phase III endpoints

BridgeBio’s stock was up after it announced the Phase III trial met its endpoints. Image credit: saepul_bahri / Shutterstock.com. BridgeBio Pharma will seek US approval of its limb-girdle muscular ...
clinicaltrialsarena

Entera’s oral osteoporosis drug meets endpoints in Phase II trial

The data was announced during the 2025 North American Menopause Society (NAMS) Annual Meeting. Image credit: shisu_ka / Shutterstock.com. Entera Bio’s osteoporosis candidate for postmenopausal women ...
clinicaltrialsarena

Inhibrx Biosciences’ stock soars on chondrosarcoma Phase II victory

Inhibrx’s DR5-targeting antibody has more than doubled PFS compared with placebo in a Phase II trial in chondrosarcoma, a rare bone cancer with no approved targeted therapies. Image credit: Kateryna ...
clinicaltrialsarena

Electra Therapeutics secures $183m to fund Phase II/III trial of ELA026

Electra is assessing ELA026 for haematologic cancers, following promising initial clinical data. Credit: Motortion Films / Shutterstock.com. Electra Therapeutics has raised $183m in an oversubscribed ...
clinicaltrialsarena

Neuphoria scraps social anxiety hopeful after Phase III miss

Neuphoria Therapeutics’ lead candidate, BNC210, has failed to show efficacy in the Phase III AFFIRM-1 trial in social anxiety disorder. Image credit: Blueastro via Shutterstock.com. Neuphoria ...